Biomerica opened higher at $1.52, compared with its previous close of $1.51. In the last trading session, the stock traded between $1.27 and $1.52. It showed a downward intraday trend.
Return calculator
Time Period
An investment of $100 made 5 years ago in Biomerica is now worth
$ 3.43
Resulting in a loss of
$ 96.57 (96.57%)
Invest with $1
Note: Past profits do not guarantee future returns.
Analyst Overview
No analyst rating data available.
Markets Today
Today's Change
$-0.25 (-16.56%)
Day High
$1.52
Day Low
$1.27
Day Open
$1.52
Prev Close
$1.51
Volume
30,360
1W Return
-25.84%
1M Return
-30.58%
3M Return
-19.59%
6M Return
-44.74%
1Y Return
-50.20%
Fundamentals
Market Cap ($ Mn)
6
PE Ratio
-
PB Ratio
1.95
PEG Ratio
-
ROE
-93.16%
ROCE
-91.41%
EPS (TTM)
$-0.27
Investment Returns
1 Week
-25.84%
1 Month
-30.58%
3 Months
-19.59%
6 Months
-44.74%
9 Months
-44.74%
Financials
Quarterly
All values in $ Mn
0.7
May 25
1.4
Aug 25
1.2
Nov 25
1.0
Feb 26
0.9
May 26
1.3
Aug 26
Updates
16Oct
Biomerica Q1FY27 Results: Net loss $1.2M, revenue falls 8% YoY
Net loss widened to $1.2 million from near-breakeven in prior year. Revenue declined 8.33% YoY to $1.3 million due to lower clinical lab orders. Cash reserves doubled to $2.7 million following a $2.23 million private placement. inFoods IBS Medicare claims paid at full $300 CMS rate; orders up 120% MoM. Over-the-counter sales surged 81% YoY, partially offsetting overall revenue drop.
27 days ago
26Sep
Biomerica files $250M shelf registration for mixed securities offering
Biomerica filed a shelf registration for up to $250 million in securities. Offering includes common stock, preferred stock, debt securities, and warrants. Terms for each sale will be determined at the time of the offering. Common stock closed at $2.60 on Nasdaq on September 23, 2026.
1mo ago
25Sep
Biomerica files prospectus for resale of 1.4 million shares
Biomerica filed a prospectus for the resale of up to 1,403,705 common shares. Company receives no proceeds from the sale by selling stockholders. Registration expenses are borne by Biomerica; selling expenses by stockholders. Shares have a par value of $0.08 per share.
1mo ago
1Sep
Biomerica Q4 net loss narrows 27%, revenue up 17% to $875K
Biomerica Q4 net loss narrowed 27% YoY to $1.1 million. Quarterly revenue rose 17% to $875,000 from $749,000. EPS improved to $(0.38) from $(0.69) per share. Full-year FY26 net loss decreased 24% to $3.8 million. Company raised $2.23 million in post-year-end private placement.
2mo ago
27Aug
Biomerica commences $2.23M private placement of 1.394M shares at $1.60
Biomerica commences private placement of 1,393,705 shares at $1.60 each. Transaction yields approximately $2.23 million in gross proceeds. No warrants or discounted securities included in the deal structure. Key stakeholders including board members and executives participated. Funds to support balance sheet and strategic evaluation process.
